BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 21990280)

  • 1. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.
    Poirel L; Bonnin RA; Nordmann P
    IUBMB Life; 2011 Dec; 63(12):1061-7. PubMed ID: 21990280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
    Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
    Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity.
    Imperi F; Antunes LC; Blom J; Villa L; Iacono M; Visca P; Carattoli A
    IUBMB Life; 2011 Dec; 63(12):1068-74. PubMed ID: 22034231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
    Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
    Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
    Poirel L; Nordmann P
    Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class 2 integrons in multidrug-resistant Acinetobacter baumannii circulating in different Brazilian geographic regions.
    Fonseca ÉL; Freitas Fdos S; Scheidegger ÉM; Jacinto T; Vicente AC
    Int J Antimicrob Agents; 2011 Jul; 38(1):95-6. PubMed ID: 21550785
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007.
    Pfeifer Y; Wilharm G; Zander E; Wichelhaus TA; Göttig S; Hunfeld KP; Seifert H; Witte W; Higgins PG
    J Antimicrob Chemother; 2011 Sep; 66(9):1998-2001. PubMed ID: 21693460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic basis of multidrug-resistant Acinetobacter baumannii clinical isolates from three university hospitals in Chungcheong Province, Korea.
    Koo SH; Kwon KC; Cho HH; Sung JY
    Korean J Lab Med; 2010 Oct; 30(5):498-506. PubMed ID: 20890082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.
    Bonnin RA; Nordmann P; Poirel L
    Expert Rev Anti Infect Ther; 2013 Jun; 11(6):571-83. PubMed ID: 23750729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AbaR4 replaces AbaR3 in a carbapenem-resistant Acinetobacter baumannii isolate belonging to global clone 1 from an Australian hospital.
    Hamidian M; Hall RM
    J Antimicrob Chemother; 2011 Nov; 66(11):2484-91. PubMed ID: 21873287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
    Karah N; Giske CG; Sundsfjord A; Samuelsen Ø
    Microb Drug Resist; 2011 Dec; 17(4):545-9. PubMed ID: 21830948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy.
    Zarrilli R; Casillo R; Di Popolo A; Tripodi MF; Bagattini M; Cuccurullo S; Crivaro V; Ragone E; Mattei A; Galdieri N; Triassi M; Utili R
    Clin Microbiol Infect; 2007 May; 13(5):481-9. PubMed ID: 17430339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile genetic elements in Acinetobacter antibiotic-resistance acquisition and dissemination.
    Noel HR; Petrey JR; Palmer LD
    Ann N Y Acad Sci; 2022 Dec; 1518(1):166-182. PubMed ID: 36316792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of integrons in antimicrobial susceptibility patterns of Acinetobacter baumannii.
    Lin MF; Chang KC; Yang CY; Yang CM; Xiao CC; Kuo HY; Liou ML
    Jpn J Infect Dis; 2010 Nov; 63(6):440-3. PubMed ID: 21099097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
    Lin L; Ling BD; Li XZ
    Int J Antimicrob Agents; 2009 Jan; 33(1):27-32. PubMed ID: 18790612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan.
    Huang LY; Chen TL; Lu PL; Tsai CA; Cho WL; Chang FY; Fung CP; Siu LK
    Clin Microbiol Infect; 2008 Nov; 14(11):1010-9. PubMed ID: 19040472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of multidrug-resistant Acinetobacter baumannii isolates obtained from elderly patients with respiratory tract infections.
    Canduela MJ; Gallego L; Sevillano E; Valderrey C; Calvo F; Pérez J
    J Antimicrob Chemother; 2006 Jun; 57(6):1220-2. PubMed ID: 16597632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.